News

WHO Suspendes Hydroxychloroquine Trials Pending Safety Data




Bloomberg Markets and Finance


685K


Want to watch this again later?

Sign in to add this video to a playlist.

Sign in


Like this video?

Sign in to make your opinion count.

Sign in



Don’t like this video?

Sign in to make your opinion count.

Sign in



Published on May 25, 2020

May.25 — World Health Organization Director-General Tedros Adhanom Ghebreyesus said the agency temporarily halted tests on hydroxychloroquine in its Covid-19 drug trials pending more data because of safety concerns. He spoke Monday at a press briefing in Geneva. (Excerpt)

Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close